Clinical trials for Lymphoma

94 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 2 Lymphoma #NCT06588478 #2024-515689-15-01

Étude évaluant l'efficacité et l'innocuité du PIRTOBRUTINIB chez des participants atteints de leucémie lymphoïde chronique ou de lymphome à petits lymphocytes en récidive ou réfractaire - Partie 1

B cell lymphoma Lymphocytic lymphoma None 1 2 3 or more Targeted therapy

Systemic Treatment-Naive

6 recruiting sites

Loxo Oncology

Phase 2 Lymphoma CLL & Richter's syndrome #NCT04728893 #2023-504931-42-00

[MK-1026-003] Efficacité et innocuité du NEMTABRUTINIB (MK-1026) chez les participants atteints d'hémopathies malignes - Cohortes A à C et J

B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Lymphocytic lymphoma None Treated / Controled 1 2 3 or more

Systemic Treatment-Naive

5 recruiting sites

Merck Sharp & Dohme LLC

Phase 2 Lymphoma #NCT04728893 #2023-504931-42-00

[MK-1026-003] Efficacité et innocuité du NEMTABRUTINIB (MK-1026) chez les participants atteints d'hémopathies malignes Cohorte H

B cell lymphoma Waldenström lymphoma None Treated / Controled 1 2 3 or more Chemotherapy Targeted therapy Monoclonal antibodies

Systemic Treatment-Naive

5 recruiting sites

Merck Sharp & Dohme LLC

Phase 2 Lymphoma #NCT05963074 #2023-504044-34-00

[TAILOR] Étude visant à personnaliser les schémas thérapeutiques à base d'IBRUTINIB pour les participants atteints de leucémie lymphoïde chronique/lymphome lymphocytaire à petits lymphocytes non traités auparavant

B cell lymphoma Lymphocytic lymphoma None None Systemic Treatment-Naive

5 recruiting sites

Janssen

Phase 2 Lymphoma #NCT04920617

[VITALIZE] DPX-SURVIVAC et PEMBROLIZUMAB avec et sans CYCLOPHOSPHAMIDE intermittent à faible dose, chez des sujets atteints de lymphome diffus à grandes cellules B en rechute/réfractaire

B cell lymphoma Large B cell lymphoma Indolent transformed lymphoma None Treated / Controled 2 3 or more Chemotherapy Monoclonal antibodies

Systemic Treatment-Naive

9 recruiting sites

ImmunoVaccine Technologies, Inc.

Phase 2 Lymphoma #NCT05463263

Etude de phase 1/2 sur le STP938 chez des sujets adultes atteints de lymphomes à cellules B et T en rechute/réfractaires

B cell lymphoma T cell lymphoma None 2 3 or more

Systemic Treatment-Naive

5 recruiting sites

Step Pharma, SAS

Phase 2 Lymphoma #NCT04128072

[MOGAT] MOGAMULIZUMAB et thérapie cutanée totale par faisceau d'électrons chez les patients atteints de lymphome cutané à cellules T de stade IB-IIB

T cell lymphoma Cutaneous T-cell lymphoma Early (stage I and II) 1 2 3 or more

Systemic Treatment-Naive

2 recruiting sites

EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer

Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT05006716

[CaDAnCe-101] Étude d'augmentation et d'expansion de la dose de BGB-16673 chez des participants atteints de tumeurs malignes à cellules B

B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Richter's syndrome Large B cell lymphoma Mantel cell lymphoma Follicular lymphoma Marginal zone lymphoma Waldenström lymphoma Lymphocytic lymphoma None 1 2 3 or more

Systemic Treatment-Naive

9 recruiting sites

BeOne Medecines

Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome Acute leukemia Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN) #NCT07220616 #2025-522595-87-00

Premier essai chez l'humain du DS3790a chez des participants atteints d'hémopathies malignes

None Treated / Controled 1 2 3 or more

Systemic Treatment-Naive Allogeneic stem cell transplant

1 recruiting site

Daiichi Sankyo

Phase 1 / Phase 2 Lymphoma #NCT06564038 #2024-515034-33-00

[Soundtrack-E] Étude de l'AZD0486 en monothérapie ou en association avec d'autres agents anticancéreux pour les hémopathies malignes à cellules B matures

Cohorte 2A et 2C

B cell lymphoma Mantel cell lymphoma Early (stage I and II) Disseminated (stage III and IV) 2 3 or more Targeted therapy

Systemic Treatment-Naive

4 recruiting sites

AstraZeneca